ATC code N07
| ATC code N: Nervous system | 
|---|
  | 
| ATCvet only | 
  | 
| Other ATC codes | 
ATC code N07 Other nervous system drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup N07 is part of the anatomical group N Nervous system.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN07.[5] 
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
N07A Parasympathomimetics
N07AA Anticholinesterases
- N07AA01 Neostigmine
 - N07AA02 Pyridostigmine
 - N07AA03 Distigmine
 - N07AA30 Ambenonium
 - N07AA51 Neostigmine, combinations
 
N07AB Choline esters
- N07AB01 Carbachol
 - N07AB02 Bethanechol
 
N07AX Other parasympathomimetics
- N07AX01 Pilocarpine
 - N07AX02 Choline alfoscerate
 - N07AX03 Cevimeline
 
N07B Drugs used in addictive disorders
N07BA Drugs used in nicotine dependence
- N07BA01 Nicotine
 - N07BA03 Varenicline
 - N07BA04 Cytisinicline
 
N07BB Drugs used in alcohol dependence
- N07BB01 Disulfiram
 - N07BB02 Calcium carbimide
 - N07BB03 Acamprosate
 - N07BB04 Naltrexone
 - N07BB05 Nalmefene
 
N07BC Drugs used in opioid dependence
- N07BC01 Buprenorphine
 - N07BC02 Methadone
 - N07BC03 Levacetylmethadol
 - N07BC04 Lofexidine
 - N07BC05 Levomethadone
 - N07BC06 Diamorphine
 - N07BC51 Buprenorphine, combinations
 
N07C Vertigo preparations
N07CA Antivertigo preparations
- N07CA01 Betahistine
 - N07CA02 Cinnarizine
 - N07CA03 Flunarizine
 - N07CA04 Acetylleucine
 - N07CA52 Cinnarizine, combinations
 
N07X Other nervous system drugs
N07XA Gangliosides and ganglioside derivatives
- Empty group
 
N07XX Other nervous system drugs
- N07XX01 Tirilazad
 - N07XX02 Riluzole
 - N07XX03 Xaliproden
 - N07XX04 Sodium oxybate
 - N07XX05 Amifampridine
 - N07XX06 Tetrabenazine
 - N07XX07 Fampridine
 - N07XX08 Tafamidis
 - N07XX10 Laquinimod
 - N07XX11 Pitolisant
 - N07XX12 Patisiran
 - N07XX13 Valbenazine
 - N07XX14 Edaravone
 - N07XX15 Inotersen
 - N07XX16 Deutetrabenazine
 - N07XX17 Arimoclomol
 - N07XX18 Vutrisiran
 - N07XX19 Sodium phenylbutyrate and ursodoxicoltaurine
 - N07XX21 Eplontersen
 - N07XX22 Tofersen
 - N07XX23 Troriluzole
 - N07XX59 Dextromethorphan, combinations
 
References
- ↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
 - ↑ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
 - ↑ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
 - ↑ "ATC/DDD Index 2022: code N07". WHO Collaborating Centre for Drug Statistics Methodology.
 - ↑ "ATCvet Index 2022: code QN07". WHO Collaborating Centre for Drug Statistics Methodology.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.